Anti-infective treatment of bacterial urinary tract infections

Current Medicinal Chemistry

Volumn 15, Issue 14, 2008, Pages 1412-1427

  Wagenlehner, F M E ^a   Pilatz, A ^a   Naber, K G ^b   Perletti, G ^c   Wagenlehner, C M ^d   Weidner, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d Agaplesion Evangelisches Krankenhaus Mittelhessen   (Germany)

Author keywords

Antibacterial agents; Antibiotic treatment; Antibioticresistance; Antibiotics; Chemistry; Complicated UTI; Structure activity relationships; Uncomplicated UTI; Urinary tract infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; COTRIMOXAZOLE; DAPTOMYCIN; ERTAPENEM; FOSFOMYCIN; LINEZOLID; MECILLINAM; NITROFURANTOIN; NITROXOLINE; NORFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIVMECILLINAM; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL TRIAL; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; NONHUMAN; REVIEW; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; BACTERIAL INFECTIONS; HUMANS; URINARY TRACT INFECTIONS;

EID: 47349132313     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986708784567699     Document Type: Review

References (116)

1. Foxman, B. Am. J. Med., 2002, 113(Suppl 1A), 5S-13S.
2. Warren, J. W.; Abrutyn, E.; Hebel, J. R.; Johnson, J. R.; Schaeffer, A. J.; Stamm, W. E. Clin. Infect. Dis., 1999, 29, 745-58.
3. Gales, A. C.; Jones, R. N.; Gordon, K. A.; Sader, H. S.; Wilke, W. W.; Beach, M. L.; Pfaller, M. A.; Doern, G. V. J. Antimicrob. Chemother., 2000, 45, 295-303.
4. Ruden, H.; Gastmeier, P.; Daschner, F. D.; Schumacher, M. Infection, 1997, 25, 199-202.
5. Maki, D. G.; Tambyah, P. A. Emerg. Infect. Dis., 2001, 7, 342-7.
6. Goto, T.; Nakame, Y.; Nishida, M.; Ohi, Y. Int. J. Antimicrob. Agents, 1999, 11, 227-31; discussion 237-9.
7. Donlan, R. M. Asaio J., 2000, 46, S47-52.
8. Gupta, K.; Hooton, T. M.; Stamm, W. E. Ann. Intern. Med., 2001, 135, 41-50.
9. Hooton, T. M. Infect. Dis. Clin. North. Am., 2003, 17, 303-32.
10. Kahlmeter, G. J. Antimicrob. Chemother., 2003, 51, 69-76.
11. Talan, D. A.; Stamm, W. E.; Hooton, T. M.; Moran, G. J.; Burke, T.; Iravani, A.; Reuning-Scherer, J.; Church, D. A. Jama., 2000, 283, 1583-90.
12. Karlowsky, J. A.; Kelly, L. J.; Thornsberry, C.; Jones, M. E.; Evangelista, A. T.; Critchley, I. A.; Sahm, D. F. Int. J. Antimicrob. Agents, 2002, 19, 21-31.
13. Karlowsky, J. A.; Kelly, L. J.; Thornsberry, C.; Jones, M. E.; Sahm, D. F. Antimicrob. Agents Chemother., 2002, 46, 2540-5.
14. Naber, K. G.; Schito, G.C.; Gualco, L. on behalf of the ARESC working group. In Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC): Chicago, Ilinois, USA, 2007.
15. McLuskey, K.; Cameron, S.; Hammerschmidt, F.; Hunter, W. N. Proc. Natl. Acad. Sci. USA, 2005, 102, 14221-6.
16. Patel, S. S.; Balfour, J. A.; Bryson, H. M. Drugs, 1997, 53, 637-56.
17. Schito, G. C. Int. J. Antimicrob. Agents, 2003, 22(Suppl 2), 79-83.
18. Ungheri, D.; Albini, E.; Belluco, G. J. Chemother., 2002, 14, 237-40.
19. Lecomte, F., Allaert, FA. Méd. Maladies Infect., 1996, 26, 338-343.
20. Hof, H. Immun. Infekt., 1988, 16, 220-5.
21. Conklin, J. D. Antibiot. Chemother., 1978, 25, 233-52.
22. Mazzulli, T.; Skulnick, M.; Small, G.; Marshall, W.; Hoban, D. J.; Zhanel, G. G.; Finn, S.; Low, D. E. Can. J. Infect. Dis., 2001, 12, 289-92.
23. Stein, G. E. Clin. Ther., 1999, 21, 1864-72.
24. Williams, G. J.; Wei, L.; Lee, A.; Craig, J. C. Cochrane Database Syst. Rev., 2006, 3, CD001534.
25. Koulaouzidis, A.; Bhat, S.; Moschos, J.; Tan, C.; De Ramon, A. Ann. Hepatol., 2007, 6, 119-21.
26. Sjovall, J.; Huitfeldt, B.; Magni, L.; Nord, C. E. Scand. J. Infect. Dis. Suppl., 1986, 49, 73-84.
27. Spratt, B. G. J. Antimicrob. Chemother., 1977, 3(Suppl B), 13-9.
28. Graninger, W. Int. J. Antimicrob. Agents, 2003, 22(Suppl 2), 73-8.
29. Nicolle, L. E. J. Antimicrob. Chemother., 2000, 46(Suppl 1), 35-9; discussion 63-5.
30. Nicolle, L. E.; Madsen, K. S.; Debeeck, G. O.; Blochlinger, E.; Borrild, N.; Bru, J. P.; McKinnon, C.; O'Doherty, B.; Spiegel, W.; Van Balen, F. A.; Menday, P. Scand. J. Infect. Dis., 2002, 34, 487-92.
31. Jones, R. N.; Kugler, K. C.; Pfaller, M. A.; Winokur, P. L. Diagn. Microbiol. Infect. Dis., 1999, 35, 55-63.
32. Gordon, K. A.; Jones, R. N. Diagn. Microbiol. Infect. Dis., 2003, 45, 295-301.
33. Mathai, D.; Jones, R. N.; Pfaller, M. A. Diagn. Microbiol. Infect. Dis., 2001, 40, 129-36.
34. Bouza, E.; San Juan, R.; Munoz, P.; Voss, A.; Kluytmans, J. Clin. Microbiol. Infect., 2001, 7, 523-31.
35. Wagenlehner, F. M.; Niemetz, A.; Weidner W.; Naber, K. G. Int. J. Antimicrob. Agents, 2008, 31(Suppl 1), S25-34.
36. Bjerklund Johansen, T. E.; Cek, M.; Naber, K.; Stratchounski, L.; Svendsen, M. V.; Tenke, P. Eur. Urol., 2007, 51, 1100-11; discussion 1112.
37. Livermore, D. M.; Woodford, N. Trends Microbiol., 2006, 14, 413-20.
38. Ena, J.; Arjona, F.; Martinez-Peinado, C.; Lopez-Perezagua Mdel, M.; Amador, C. Urology, 2006, 68, 1169-74.
39. Luna, C. M.; Vujacich, P.; Niederman, M. S.; Vay, C.; Gherardi, C.; Matera, J.; Jolly, E. C. Chest, 1997, 111, 676-85.
40. Montravers, P.; Gauzit, R.; Muller, C.; Marmuse, J. P.; Fichelle, A.; Desmonts, J. M. Clin. Infect. Dis., 1996, 23, 486-94.
41. Elhanan, G.; Sarhat, M.; Raz, R. J. Infect., 1997, 35, 283-8.
42. Donowitz, G. R.; Mandell, G. L. N. Engl. J. Med., 1988, 318, 419-26.
43. Nathwani, D.; Wood, M. J. Drugs, 1993, 45, 866-94
44. Drusano, G. L.; Schimpff, S. C.; Hewitt, W. L. Rev. Infect. Dis., 1984, 6, 13-32.
45. Slocombe, B.; Basker, M. J.; Bentley, P. H.; Clayton, J. P.; Cole, M.; Comber, K. R.; Dixon, R. A.; Edmondson, R. A.; Jackson, D.; Merrikin, D. J.; Sutherland, R. Antimicrob. Agents Chemother., 1981, 20, 38-46.
46. Jules, K.; Neu, H. C. Antimicrob. Agents Chemother., 1982, 22, 453-60.
47. Kosmidis, J. Drugs, 1985, 29(Suppl 5), 172-4.
48. Marshall, W. F.; Blair, J. E. Mayo Clin. Proc., 1999, 74, 187-95.
49. Jones, R. N.; Preston, D. A. Postgrad. Med. J., 1983, 59(Suppl 5), 9-15.
50. Smith, B. R.; LeFrock, J. L. Ther. Drug Monit., 1983, 5, 149-60.
51. Brogard, J. M.; Jehl, F.; Willemin, B.; Lamalle, A. M.; Blickle, J. F.; Monteil, H. Clin. Pharmacokinet., 1989, 17, 163-74.
52. Perry, C. M.; Brogden, R. N. Drugs, 1996, 52, 125-58.
53. Molavi, A. Am. Fam. Physician, 1991, 43, 937-48
54. Dudley, M. N.; Barriere, S. L. Clin. Pharm., 1982, 1, 114-24.
55. Brogden, R. N.; Ward, A. Drugs, 1988, 35, 604-45
56. Chocas, E. C.; Paap, C. M.; Godley, P. J. Ann. Pharmacother., 1993, 27, 1369-77.
57. Owens, R. C., Jr.; Nightingale, C. H.; Nicolau, D. P. Pharmacotherapy, 1997, 17, 707-20.
58. Bergogne-Berezin, E. Press. Med., 1988, 17, 1878-1882.
59. Wynd, M. A.; Paladino, J. A. Ann. Pharmacother., 1996, 30, 1414-24.
60. Murthy, B.; Schmitt-Hoffmann, A. Clin. Pharmacokinet., 2008, 47, 21-33.
61. Noel, G. J.; Strauss, R. S.; Amsler, K.; Heep, M.; Pypstra, R.; Solomkin, J. S. Antimicrob. Agents Chemother., 2008, 52, 37-44.
62. Talbot, G. H.; Thye, D.; Das, A.; Ge, Y. Antimicrob. Agents Chemother., 2007, 51, 3612-6.
63. Kumagai, T., Tamai, S, Abe, T, Hikida, M. Curr. Med. Chem. - Anti-Infect. Agents, 2002, 1, 1-14.
64. Hammond, M. L. J. Antimicrob. Chemother., 2004, 53(Suppl 2), ii7-9.
65. Shah, P. M.; Isaacs, R. D. J. Antimicrob. Chemother., 2003, 52, 538-42.
66. Hellinger, W. C.; Brewer, N. S. Mayo Clin. Proc., 1999, 74, 420-34.
67. Jones, R. N.; Sader, H. S.; Fritsche, T. R. Diagn. Microbiol. Infect. Dis., 2005, 52, 71-4.
68. Naber, K.; Redman, R.; Kotey P.; Llorens, L.; Kaniga, K. In 25th ICC, 17th ECCMID: Munich, Germany, 2007; Vol. Poster 833.
69. Dalhoff, A.; Janjic, N.; Echols, R. Biochem. Pharmacol., 2006, 71, 1085-95.
70. Muratani, T.; Iihara, K.; Nishimura, T.; Inatomi, H.; Fujimoto, N.; Kobayashi, T.; Yamada, Y.; Takahashi, K.; Matsumoto, T. Kansenshogaku Zasshi, 2002, 76, 928-38.
71. Mingeot-Leclercq, M. P.; Glupczynski, Y.; Tulkens, P. M. Antimicrob. Agents Chemother., 1999, 43, 727-37.
72. Benveniste, R.; Davies, J. Antimicrob. Agents Chemother., 1973, 4, 402-9.
73. Mingeot-Leclercq, M. P.; Tulkens, P. M. Antimicrob. Agents Chemother., 1999, 43, 1003-12.
74. Giuliano, R. A.; Verpooten, G. A.; Verbist, L.; Wedeen, R. P.; De Broe, M. E. J. Pharmacol. Exp. Ther., 1986, 236, 470-5
75. Verpooten, G. A.; Giuliano, R. A.; Verbist, L.; Eestermans, G.; De Broe, M. E. Clin. Pharmacol. Ther., 1989, 45, 22-7.
76. Hvidberg, H.; Struve, C.; Krogfelt, K. A.; Christensen, N.; Rasmussen, S. N.; Frimodt-Moller, N. Antimicrob. Agents Chemother., 2000, 44, 156-63.
77. Sturm, W. J. Chemother., 1995, 7(Suppl 2), 149-54.
78. Hodson, E. M.; Willis, N. S.; Craig, J. C. Cochrane Database Syst. Rev., 2007, CD003772.
79. Naber, K. G.; Adam, D. Int. J. Antimicrob. Agents, 1998, 10, 255-7.
80. Park-Wyllie, L. Y.; Juurlink, D. N.; Kopp, A.; Shah, B. R.; Stukel, T. A.; Stumpo, C.; Dresser, L.; Low, D. E.; Mamdani, M. M. N. Engl. J. Med., 2006, 354, 1352-61.
81. Van Bambeke, F.; Michot, J. M.; Van Eldere, J.; Tulkens, P. M. Clin. Microbiol. Infect., 2005, 11, 256-80.
82. Okhamafe, A. O.; Akerele, J. O.; Chukuka, C. S. Int. J. Pharm., 1991, 68, 11-18.
83. Sorgel, F.; Kinzig, M. Am. J. Med., 1993, 94, 56S-69S.
84. Naber, K. G. Int. J. Antimicrob. Agents, 2001, 17, 331-41.
85. Stamey, T. A.; Bushby, S. R.; Bragonje, J. J. Infect. Dis., 1973, 128, Suppl:686-92 p.
86. Stamey, T. A.; Meares, E. M., Jr.; Winningham, D. G. J. Urol., 1970, 103, 187-94.
87. Naber, K. G.; Sorgel, F. Andrologia, 2003, 35, 331-5.
88. Smilack, J. D. Mayo Clin. Proc., 1999, 74, 730-4
89. Raz, R.; Chazan, B.; Kennes, Y.; Colodner, R.; Rottensterich, E.; Dan, M.; Lavi, I.; Stamm, W. Clin. Infect. Dis., 2002, 34, 1165-9.
90. Laupland, K. B.; Ross, T.; Pitout, J. D.; Church, D. L.; Gregson, D. B. Infection, 2007, 35, 150-3.
91. Kahlmeter, G. Int. J. Antimicrob. Agents, 2003, 22(Suppl 2), 49-52.
92. Nicolle, L. E.; Harding, G. K.; Thomson, M.; Kennedy, J.; Urias, B.; Ronald, A. R. J Infect. Dis., 1988, 157, 1239-42
93. Meares, E. M., Jr. Rev. Infect. Dis., 1982, 4, 475-83.
94. Hofstetter, A.; Friesen, A.; Bishop-Freudling, G. B.; Vergin, H. Fortschr. Med., 1984, 102, 244-6.
95. Hanus, P. M.; Danziger, L. H. Clin. Pharm., 1984, 3, 49-55.
96. Naber, K. G.; Bergman, B.; Bishop, M. C.; Bjerklund-Johansen, T. E.; Botto, H.; Lobel, B.; Jinenez Cruz, F.; Selvaggi, F. P. Eur. Urol., 2001, 40, 576-88.
97. Hermans, P. E.; Wilhelm, M. P. Mayo Clin. Proc., 1987, 62, 901-5.
98. Zhanel, G. G.; Laing, N. M.; Nichol, K. A.; Palatnick, L. P.; Noreddin, A.; Hisanaga, T.; Johnson, J. L.; Hoban, D. J. J. Antimicrob. Chemother., 2003, 52, 382-8.
99. Shinabarger, D. Expert Opin. Investig. Drugs, 1999, 8, 1195-202.
100. Conte, J. E., Jr.; Golden, J. A.; Kipps, J.; Zurlinden, E. Antimicrob. Agents Chemother., 2002, 46, 1475-80.
101. MacGowan, A. P. J. Antimicrob. Chemother., 2003, 51(Suppl 2), ii17-25.
102. Wagenlehner, F. M.; Lehn, N.; Witte, W.; Naber, K. G. Chemotherapy, 2005, 51, 64-9.
103. Wagenlehner, F. M.; Wydra, S.; Onda, H.; Kinzig-Schippers, M.; Sorgel, F.; Naber, K. G. Antimicrob. Agents Chemother., 2003, 47, 3789-94.
104. Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J. Lancet, 2001, 358, 207-8.
105. Balbi, H. J. Pediatr. Rev., 2004, 25, 284-8.
106. Steenbergen, J. N.; Alder, J.; Thorne, G. M.; Tally, F. P. J. Antimicrob. Chemother., 2005, 55, 283-8.
107. Pelletier, C.; Prognon, P.; Bourlioux, P. Antimicrob. Agents Chemother., 1995, 39, 707-13.
108. Strachunskii, L. S.; Sekhin, S. V.; Abramova, E. R.; Reshed'ko, G. K.; Petrochenkova, N. A.; Eidel'shtein, I. A.; Suvorov, M. M.; Krechikova, O. I.; Il'ina, V. N.; Petrova, T. A.; Gugutsidze, E. N.; Furletova, N. M. Ter. Arkh., 2000, 72, 30-5.
109. Falagas, M. E.; Kasiakou, S. K. Clin. Infect. Dis., 2005, 40, 1333-41.
110. Agwuh, K. N.; MacGowan, A. J. Antimicrob. Chemother., 2006, 58, 256-65.
111. Cheng, Q.; Nelson, D.; Zhu, S.; Fischetti, V. A. Antimicrob. Agents Chemother., 2005, 49, 111-7.
112. Yoong, P.; Schuch, R.; Nelson, D.; Fischetti, V. A. J. Bacteriol., 2004, 186, 4808-12.
113. Bulitta, J.; Kinzig-Schippers, M.; Naber, C.K.; Naber, K.G.; Sauber, S.; Kleinschnitz, M.; Wahode, H.; Rodamer, M.; Soergel, F. In 40th Interscience conference on antimicrobial agents and chemotherapy; American society for microbiology, ed.; American society for microbiology: Toronto, 2000, pp. 506.
114. Wagenlehner, F. M.; Kees, F.; Weidner, W.; Wagenlehner, C.; Naber, K. G. Int. J. Antimicrob. Agents, 2008, 31, 21-6.
115. MacGowan, A. P. Expert Opin. Investig. Drugs, 1999, 8, 181-199.
116. Soergel, F.; Bulitta, J.; Kinzig-Schippers, M. Chemother. J., 2002, 11, 25-33.